Tekla Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tekla Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,781	Closed	-$490K	–	213
2018 Q3	$490K	Hold	22,781	–	–	0.02%	198
2018 Q2	$976K	Hold	22,781	–	–	0.04%	158
2018 Q1	$1.49M	Buy	+22,781	New	+$1.61M	0.06%	148

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tekla Capital Management's LUMO Position: Q4 2018 in Review

Tekla Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018, closing a stake of 22,781 shares — an estimated $490K sold.

Tekla Capital Management first reported a position in LUMO in Q1 2018 and held it in 3 quarters. The position peaked at $1.49M in Q1 2018. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

Tekla Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Tekla Capital Management sold 22,781 Lumos Pharma, Inc. Common Stock shares in Q4 2018, an estimated $490K.
Tekla Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Tekla Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $1.49M in Q1 2018.
87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Tekla Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.